Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Harae Dx Corp. logo — Harae Dx is developing the worlds first low-cost portable Au...

Harae Dx Corp.

Harae Dx is developing the worlds first low-cost portable Automated cancer detection system

Founded 2021 United States Pleasanton, United States 6 employees Series A Total: $350.00K Biotechnology, Health Care

General Information

Company Name Harae Dx Corp.
Founded Year 2021
Location United States Pleasanton, United States +1
Founders / Decision Makers
Team member
Employees 6
Industries Biotechnology, Health Care
Funding Stage Series A
Social

Get notified when Harae Dx Corp. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Harae Dx Corp.

Harae Dx Corp., founded in 2021, is making waves in the Biotechnology and Health Care industries with its groundbreaking innovation: the world's first low-cost, portable, and fully automated AI-based cancer detection system.

Headquartered in the United States, the company is focused on providing affordable and accessible diagnostic solutions for multiple cancers, including ovarian, cervical, and breast cancer. This cutting-edge technology aims to significantly reduce diagnostic costs, thereby democratizing access to critical health services.

Harae Dx recently secured Series A investment funding on 12 December 2022 from PreAngel, underscoring investor confidence in its potential to disrupt traditional cancer diagnostics. By leveraging AI, the company is poised to transform how the healthcare industry approaches early disease detection, making it a promising venture for stakeholders seeking impactful and scalable investment opportunities.

Taxonomy: Medical Device, Cancer Detection, Diagnostic Technology, AI-based, Portable, Automated System, Molecular Diagnostics, Point of Care, Ovarian Cancer, Cervical Cancer, Breast Cancer, Low-cost, Early Detection, Healthcare Innovation

Services & Products

Automated Cancer Detection
AI-powered Diagnostic Solutions
Early Detection of Breast Cancer

Target Customers

Healthcare Providers Hospitals Diagnostic Laboratories Clinicians

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1
Investor
01 Dec 2022
Convertible Note •••••• 1
Investor
01 Mar 2022
Seed •••••• 2
Investor Investor
01 Apr 2021

Harae Dx Corp. Alternatives & Competitors

Harae Dx Corp. vs
Micromedic Technologies Ltd.
Micromedic Technologies Ltd. Israel

Micromedic Technologies specializes in the development and commercialization of innovative in vitro...

Post Ipo Equity
1 employees
Health Care
Harae Dx Corp. vs
Beacon Biomedical
Beacon Biomedical United States

Easy, Accurate & Affordable Blood Based Screening for early detection of cancer and COVID-19 detecti...

Acquired
1 employees
Biotechnology, Health Care
Harae Dx Corp. vs
ClearNote Health
ClearNote Health United States

Cancer detection company enabling people at risk for high-mortality cancers to live longer, healthie...

57 employees
Also compare with: Harae Dx Corp. vs Harbinger Health Harbinger Health

FAQ About Harae Dx Corp.

Harae Dx is developing the worlds first low-cost portable Automated cancer detection system
Harae Dx Corp. was founded in 2021.
Harae Dx Corp. is headquartered in Pleasanton, United States.
Harae Dx Corp. operates in the following industries: Biotechnology, Health Care.
Harae Dx Corp. has approximately 6 employees.
Harae Dx Corp. has completed 3 funding rounds, raising a total of $350.00K. The latest funding stage is Series A.
Harae Dx Corp. offers: Automated Cancer Detection, AI-powered Diagnostic Solutions, Early Detection of Breast Cancer.
Top alternatives and competitors to Harae Dx Corp. include Micromedic Technologies Ltd., Beacon Biomedical, ClearNote Health, Nucleix Ltd., Previse. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Harae Dx Corp. and Micromedic Technologies Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Harae Dx Corp. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy